Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20343)

Filter results: >>>>
  • Page 1 of 429
  • 1 to 25 of 10710 records
Cell Small Molecule Small Mol Concentration (uM) Primary Target Pathway Mean Normalized Growth Rate Inhibition Value Increased Fraction Dead
BT-20 Palbociclib
0.1
CDK4/6
Cell cycle
0.3557 0.03619
BT-20 AZD7762
0.1
CHK1/2
Cell cycle
1.1714 0.04490
BT-20 Abemaciclib
1.0
CDK4/6
Cell cycle
0.2233 0.00560
BT-20 Palbociclib
0.031623
CDK4/6
Cell cycle
0.5715 0.01511
BT-20 AZD7762
0.001
CHK1/2
Cell cycle
1.1198 -0.00253
BT-20 AZD7762
0.031623
CHK1/2
Cell cycle
1.2229 0.01175
BT-20 Abemaciclib
0.01
CDK4/6
Cell cycle
0.7022 -0.00034
BT-20 Abemaciclib
0.31623
CDK4/6
Cell cycle
0.2635 0.00452
BT-20 Palbociclib
0.00031623
CDK4/6
Cell cycle
1.0619 -0.00163
BT-20 Palbociclib
0.01
CDK4/6
Cell cycle
0.8023 0.00566
BT-20 Palbociclib
1.0
CDK4/6
Cell cycle
0.2044 0.04646
BT-20 Palbociclib
3.1623
CDK4/6
Cell cycle
0.1624 0.05010
BT-20 AZD7762
0.0031623
CHK1/2
Cell cycle
1.2431 -0.00726
BT-20 AZD7762
0.01
CHK1/2
Cell cycle
1.2200 0.00225
BT-20 Abemaciclib
0.001
CDK4/6
Cell cycle
0.9370 -0.00149
BT-20 Abemaciclib
0.0031623
CDK4/6
Cell cycle
0.8833 -0.00527
BT-20 Abemaciclib
0.031623
CDK4/6
Cell cycle
0.4936 -0.00426
BT-20 Abemaciclib
0.1
CDK4/6
Cell cycle
0.3565 0.00950
BT-20 Abemaciclib
3.1623
CDK4/6
Cell cycle
0.1622 0.01068
BT-20 Abemaciclib
10.0
CDK4/6
Cell cycle
-0.2160 0.37259
BT-20 Palbociclib
0.001
CDK4/6
Cell cycle
1.0987 -0.00539
BT-20 Palbociclib
0.0031623
CDK4/6
Cell cycle
0.9966 0.00011
BT-20 Palbociclib
0.31623
CDK4/6
Cell cycle
0.2359 0.04751
BT-20 AZD7762
1.0
CHK1/2
Cell cycle
0.5068 0.21188
BT-20 AZD7762
0.31623
CHK1/2
Cell cycle
0.9454 0.07692
  • Page 1 of 429
  • 1 to 25 of 10710 records